(Q43463539)

23 November 2017

Coexistence and competition in HIV infections (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1296094

10 September 2022

1 reference

https://api.crossref.org/works/10.1016/S0022-5193(05)80728-3

28 November 2023

modeling and simulation

1 reference

https://api.crossref.org/works/10.1016/S0022-5193(05)80728-3

Robert May, Baron May of Oxford

28 November 2023

author

object named as

R M May

series ordinal

2

0 references

author name string

M. A. Nowak

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1296094

10 September 2022

R. M. May

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1296094

10 September 2022

language of work or name

English

0 references

publication date

1 December 1992

1 reference

23 November 2017

7 December 1992

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1296094

full work available at URL

10 September 2022

number of pages

14

1 reference

based on heuristic

inferred from page(s)

https://api.elsevier.com/content/article/PII:S0022519305807283?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0022-5193(05)80728-3

https://api.elsevier.com/content/article/PII:S0022519305807283?httpAccept=text/plain

28 November 2023

1 reference

https://api.crossref.org/works/10.1016/S0022-5193(05)80728-3

Journal of Theoretical Biology

28 November 2023

published in

1 reference

23 November 2017

159

1 reference

23 November 2017

329-342

1 reference

23 November 2017

3

1 reference

Rapid development of isolate-specific neutralizing antibodies after primary HIV-1 infection and consequent emergence of virus variants which resist neutralization by autologous sera.

23 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5193%2805%2980728-3

Possible demographic consequences of AIDS in developing countries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5193%2805%2980728-3

The spread of HIV-1 in Africa: sexual contact patterns and the predicted demographic impact of AIDS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5193%2805%2980728-3

Isolation of a T-Lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5193%2805%2980728-3

Biologic features of HIV-1 that correlate with virulence in the host

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5193%2805%2980728-3

Plasma viremia in human immunodeficiency virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5193%2805%2980728-3

Neutralization of diverse HIV-1 strains by monoclonal antibodies raised against a gp41 synthetic peptide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5193%2805%2980728-3

How old is the immunodeficiency virus?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5193%2805%2980728-3

Competitive coexistence of self-reproducing macromolecules

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5193%2805%2980728-3

Biologically diverse molecular variants within a single HIV-1 isolate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5193%2805%2980728-3

Isolation of human T-cell leukemia virus in acquired immune deficiency syndrome (AIDS)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5193%2805%2980728-3

Genetic variation in HTLV-III/LAV over time in patients with AIDS or at risk for AIDS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5193%2805%2980728-3

Quantitation of human immunodeficiency virus type 1 in the blood of infected persons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5193%2805%2980728-3

Competition and cooperation in catalytic selfreplication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5193%2805%2980728-3

Broadly neutralizing antibodies elicited by the hypervariable neutralizing determinant of HIV-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5193%2805%2980728-3

Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5193%2805%2980728-3

Type-Restricted Neutralization of Molecular Clones of Human Immunodeficiency Virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5193%2805%2980728-3

Characterization of HIV-1 neutralization escape mutants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5193%2805%2980728-3

Models of interactions between HIV and other pathogens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5193%2805%2980728-3

Temporal fluctuations in HIV quasispecies in vivo are not reflected by sequential HIV isolations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5193%2805%2980728-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5193%2805%2980728-3

Variability of HIV infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5193%2805%2980728-3

Antigenic Diversity Thresholds and the Development of AIDS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5193%2805%2980728-3

Mathematical biology of HIV infections: antigenic variation and diversity threshold

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5193%2805%2980728-3

The evolutionary dynamics of HIV-1 quasispecies and the development of immunodeficiency disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5193%2805%2980728-3

Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5193%2805%2980728-3

Extensive variation of human immunodeficiency virus type-1 in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5193%2805%2980728-3

HIV genome variability in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5193%2805%2980728-3

Variable and conserved neutralization antigens of human immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5193%2805%2980728-3

Concurrent evolution of human immunodeficiency virus type 1 in patients infected from the same source: rate of sequence change and low frequency of inactivating mutations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5193%2805%2980728-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Evidence for a role of virulent human immunodeficiency virus (HIV) variants in the pathogenesis of acquired immunodeficiency syndrome: studies on sequential HIV isolates

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5193%2805%2980728-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

1 reference

23 November 2017

1 reference